Phase 2 Cystic Fibrosis Trial, Recruiting NCT07547436 Sponsor: Sanofi Condition: Cystic Fibrosis
Back to Cystic Fibrosis

Phase 2 Cystic Fibrosis Trial, Recruiting

NCT07547436
Recruiting Phase 2

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 18 and 80 years old at the time of signing the consent form
  • You have a history of symptoms consistent with non-cystic fibrosis bronchiectasis, such as a long-term productive cough and/or repeated chest infections
  • You have had at least 2 chest infection episodes in the past 12 months that required a doctor to prescribe antibiotics (by mouth or through a drip) for 5 or more days
  • A CT scan of your chest has confirmed that you have bronchiectasis
  • Your CT scan shows a minimum level of disease severity based on a specific scoring system (confirm with trial site)
  • You are currently producing mucus/phlegm and have been doing so regularly for at least 3 months within the past year
  • Your lung function test (a breathing test measuring airflow) shows your lungs are working at least 30% of the expected normal level after using a bronchodilator (an inhaler that opens the airways)

Who may not be able to join:

  • Your main diagnosis is COPD caused by smoking, or asthma, as decided by the doctor running the trial
  • You have been diagnosed with a specific type of allergic lung condition caused by fungi (confirm with trial site)
  • You have an active lung infection caused by a group of bacteria called non-tuberculous mycobacteria, or you have not completed treatment for such an infection
  • Your bronchiectasis is caused by cystic fibrosis, a specific immune deficiency condition, a genetic lung condition, or a condition affecting the tiny hairs in your airways (confirm with trial site)
  • You have had a serious episode of coughing up blood that required medical treatment or a blood transfusion
  • You are currently a smoker
  • You have a known or suspected problem with your immune system, including a history of certain serious or unusual infections, or infections that keep coming back more than expected
  • You have an active autoimmune disease (where the immune system attacks the body) or are taking medication to suppress the immune system for such a condition, including conditions like lupus, rheumatoid arthritis, inflammatory bowel disease, multiple sclerosis, or psoriasis, among others

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Phone: 800-633-1610

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 2
Sponsor
Registry
ClinicalTrials.gov
Start date
8 June 2026
Est. completion
29 October 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change from baseline to Week 24 in mucus plug score (MPS) derived from chest high-resolution computerized tomography (HRCT)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov